These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29287586)

  • 1. The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study.
    Ma Y; Han F; Chen L; Wang H; Han H; Yu B; Xu Y; Chen J
    BMC Nephrol; 2017 Dec; 18(1):381. PubMed ID: 29287586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of protein A immunoadsorption therapy on severe ANCA-associated vasculitis renal injury.
    Song J; Liu H; Chen X; Zhou L; Sun C; Yuan F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1026-1032. PubMed ID: 37724405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Outcomes in Older Adults with Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: A New Prediction Model.
    Zhang S; Chen X; Hou Z; Xia P; Shi X; Wu H; Wen Y; Qin Y; Tian X; Chen L
    Am J Nephrol; 2023; 54(9-10):399-407. PubMed ID: 37708862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of monoclonal protein in ANCA-associated vasculitis with renal involvement.
    Wang Y; Yang K; Yu Z; Huang Y; He T; Xiong J; Zhao J
    Int Urol Nephrol; 2023 Nov; 55(11):2925-2933. PubMed ID: 37010735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery and long-term renal outcome of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis who are on dialysis at presentation.
    Lee YJ; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    J Rheum Dis; 2023 Oct; 30(4):251-259. PubMed ID: 37736589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and prognosis of acute renal failure on dialysis in ANCA vasculitis].
    Siham A; Hafedh F; Jean-Jacques B; Pierre-Antoine M
    Nephrol Ther; 2024 Feb; 20(1):5-16. PubMed ID: 38282439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV.
    Wang C; Li ZY; Jiang GP; Zhao MH; Chen M
    Clin Exp Med; 2024 Apr; 24(1):88. PubMed ID: 38683496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANCA negative pulmonary vasculitis: a challenging diagnosis.
    Zhang Y; Mayor K; Mahdi A
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38901853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Thyroid Function in ANCA-Associated Vasculitis Patients with Renal Injury.
    Yu W; Wang Y; Ma L; Gou S; Fu P
    J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney involvement in myelodysplastic syndromes.
    Lafargue MC; Duong Van Huyen JP; Rennke HG; Essig M; Bobot M; Jourde-Chiche N; Sakhi H; Karras A; Boudhabhay I; Brunet P; Boulay H; Grobost V; Philipponnet C; Jeannel J; Chemouny J; Boffa JJ; Braham-Stambouli D; Selamet U; Riella LV; Fain O; Adès L; Fenaux P; Cohen C; Mekinian A
    Clin Kidney J; 2024 Aug; 17(8):sfae185. PubMed ID: 39099564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Almaani S; Song H; Suthanthira M; Toy C; Fussner LA; Meara A; Nagaraja H; Cuthbertson D; Khalidi NA; Koening CL; Langford CA; McAlear CA; Moreland LW; Pagnoux C; Seo P; Specks U; Sreih AG; Warrington KJ; Monach PA; Merkel PA; Rovin B; Birmingham D
    Kidney Int Rep; 2023 Nov; 8(11):2421-2427. PubMed ID: 38025219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and clinical predictors of infections in patients treated with severe systemic ANCA-associated vasculitis.
    Haris Á; Polner K; Arányi J; Braunitzer H; Kaszás I
    Physiol Int; 2021 Mar; ():. PubMed ID: 33769957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and time-dependent increases in incident anti-glomerular basement membrane disease: a nationwide cohort study.
    Nelveg-Kristensen KE; Madsen B; McClure M; Bruun N; Lyngsø C; Dieperink H; Gregersen JW; Krarup E; Ivarsen P; Torp-Pedersen C; Egfjord M; Szpirt W; Carlson N;
    Clin Kidney J; 2024 Jan; 17(1):sfad261. PubMed ID: 38186880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis.
    Houben E; Groenland SL; van der Heijden JW; Voskuyl AE; Doodeman HJ; Penne EL
    BMC Nephrol; 2017 Dec; 18(1):378. PubMed ID: 29287588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Schönlein purpura, ankylosing spondylitis, and Raynaud's phenomenon.
    Taha R; El-Haddad H; Almuallim A; Alshaiki F; Obaid E; Almoallim H
    Open Access Rheumatol; 2017; 9():201-214. PubMed ID: 29290695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
    Schirmer JH; Sanchez-Alamo B; Hellmich B; Jayne D; Monti S; Luqmani RA; Tomasson G
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37479496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between myeloperoxidase-antineutrophil cytoplasmic autoantibody (ANCA) and proteinase 3-ANCA associated vasculitis: A retrospective study from a single center in China.
    Wu T; Shen C; Zhong Y; Ooi JD; Zhou YO; Chen JB; Meng T; Xiao Z; Lin W; Ao X; Xiao X; Zhou Q; Xiao P
    Exp Ther Med; 2021 Jun; 21(6):561. PubMed ID: 33850533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomatosis With Polyangiitis and Microscopic Polyangiitis: A Systematic Review and Meta-Analysis of Benefits and Harms of Common Treatments.
    Springer JM; Kalot MA; Husainat NM; Byram KW; Dua AB; James KE; Chang Lin Y; Turgunbaev M; Villa-Forte A; Abril A; Langford C; Maz M; Chung SA; Mustafa RA
    ACR Open Rheumatol; 2021 Mar; 3(3):196-205. PubMed ID: 33590973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study.
    Chanouzas D; McGregor JAG; Nightingale P; Salama AD; Szpirt WM; Basu N; Morgan MD; Poulton CJ; Draibe JB; Krarup E; Dospinescu P; Dale JA; Pendergraft WF; Lee K; Egfjord M; Hogan SL; Harper L
    BMC Nephrol; 2019 Feb; 20(1):58. PubMed ID: 30777023
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.